otoancorin Activators
Otoancorin Activators are a set of compounds designed to influence Otoancorin function, either directly or indirectly. They predominantly target pathways implicated in cochlear development, cell differentiation, and membrane integrity, such as the cAMP-PKA pathway influenced by Forskolin and IBMX. While these compounds themselves may not act directly on Otoancorin, they can affect other molecules and pathways crucial for Otoancorin's proper function. For example, retinoic acid activates RAR/RXR nuclear receptors, which have a role in inner ear development and could increase the expression or activity of Otoancorin.
Similarly, some compounds, such as Dexamethasone and EGF, exert their influence via glucocorticoid and EGF receptors, respectively. Their activation triggers a downstream cascade of events that can involve Otoancorin indirectly. The phosphoinositide pathway, essential for cell differentiation and function in the cochlea, can also be influenced by PMA's activation of PKC. These pathways offer a likely environment in which Otoancorin can be activated to perform its specialized function in cochlear mechanics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels, activating PKA. PKA can influence inner ear development, possibly increasing the demand for Otoancorin. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Raises cAMP levels, similar to Forskolin, indirectly affecting Otoancorin through PKA. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Activates RAR/RXR nuclear receptors, which have a role in inner ear development, potentially increasing Otoancorin activity. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Activates glucocorticoid receptor, affecting inner ear development which can potentially require Otoancorin for membrane anchoring. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
JNK pathway activator, potentially affecting Otoancorin by influencing inner ear cell differentiation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, thereby affecting inner ear function, possibly requiring Otoancorin for membrane integrity. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $77.00 $179.00 | 18 | |
Alters lipid metabolism, affecting cell membrane composition in the cochlea, possibly requiring Otoancorin for function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor, influences cell differentiation in the inner ear, possibly affecting Otoancorin expression. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, affecting the function of cells in the cochlea, possibly influencing Otoancorin. | ||||||